Clinical Trials in Tennessee

Showing 10101-10120 of 15,329 trials

Brain Penetrance of 2-HOBA in Humans

NCT03554096

The purpose of this study is to confirm that 2-HOBA crosses the blood brain barrier and to compare blood and cerebrospinal fluid levels of 2-HOBA after a single oral dose.

Healthy Adults

Metabolic Technologies Inc.3 participantsStarted May 2018

Nashville, Tennessee, United States

COMPLETEDNA29 miles

Aortic Valve Replacement With Trifecta(TM)

NCT00475709

To confirm the clinical safety and effectiveness of the Trifecta valve.

Aortic Valve InsufficiencyRegurgitation, Aortic ValveAortic Valve Incompetence+1 more

Abbott Medical Devices1,022 participantsStarted Jun 2007

Los Angeles, California, United States • Sarasota, Florida, United States • Maywood, Illinois, United States +15 more locations

Brain Penetrance of 2-HOBA in Humans

Aortic Valve Replacement With Trifecta(TM)

Find Trials by Condition in Tennessee

Detect Fluid Early From Intra-thoracic Impedance Monitoring

Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds

GSK1120212 Rollover Study

Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne

GLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular Ultrasound

Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD

Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)

Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS)

Thyroid Therapy for Mild Thyroid Deficiency in Pregnancy

Veterans Individual Placement and Support Towards Advancing Recovery

eHealth Partnered Evaluation Initiative

Pediatric Inflammatory Bowel Disease Collaborative Research Group Registry

Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer

Placebo-controlled, Dose-escalation Study of the Safety of IMO-2125 (Immunomodulatory Oligonucleotide) in Hepatitis C-infected Patients

CONcomitant eValuation of Epicor Left atRial Therapy for AF

A Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets in Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy [HIBM]) Patients With Severe Ambulatory Impairment

A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen

Heart Outcomes Prevention and Evaluation 4